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Abstract
Rapid antibiotic susceptibility testing of Mycobacterium tuberculosis is of paramount importance as multiple- and
extensively- drug resistant strains of M. tuberculosis emerge and spread. We describe here a virus-based assay in which
fluoromycobacteriophages are used to deliver a GFP or ZsYellow fluorescent marker gene to M. tuberculosis, which can then
be monitored by fluorescent detection approaches including fluorescent microscopy and flow cytometry. Pre-clinical
evaluations show that addition of either Rifampicin or Streptomycin at the time of phage addition obliterates fluorescence
in susceptible cells but not in isogenic resistant bacteria enabling drug sensitivity determination in less than 24 hours.
Detection requires no substrate addition, fewer than 100 cells can be identified, and resistant bacteria can be detected
within mixed populations. Fluorescence withstands fixation by paraformaldehyde providing enhanced biosafety for testing
MDR-TB and XDR-TB infections.
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Introduction
Tuberculosis (TB) is a major cause of human mortality with 9
million new cases and nearly two million deaths annually;
approximately two billion peoples are infected with the causative
agent, Mycobacterium tuberculosis [1]. While M. tuberculosis infections
can be effectively resolved with a standard 6–9 month course of
antibiotics with at least three drugs, the emergence of drug
resistant strains severely complicates treatment. Of particular
concern are those strains that are resistant to two or more of the
first-line anti-tuberculosis drugs, including multidrug resistant
(MDR) – resistant to rifampicin and isoniazid – and extensively
drug resistant-tuberculosis (XDR) strains that are resistant to
rifampicin, isoniazid, a second line injectable drug (capreomycin,
kanamycin or amikacin) and a fluoroquinolone [2,3]. The
devastating impact of XDR TB infections – especially in
combination with HIV infection – was demonstrated by an
outbreak in Tugela Ferry, KwaZulu-Natal, South Africa, in which
52 of 53 patients died with a median time-to-death after sputum
collection of 16 days [4].
A variety of diagnostic tools have been developed for detection
and drug susceptibility testing of M. tuberculosis. The cornerstone is
sputum smear microscopy, a cheap and simple test to detect the
presence of acid-fast bacilli in patient’s sputum, but which requires
a minimum of 10,000 bacteria per ml of sputum, and cannot
simply discern drug susceptibilities [1,5]. In contrast, drug
resistance profiles can be readily determined using sensitive and
automated radiometric methods or by DNA-based technologies,
but these can be time-consuming and expensive, limiting their
applicability in the developing world where the vast majority of
TB cases occur [5]. There is therefore a need for new diagnostic
approaches that combine speed (time-to-detection), sensitivity,
specificity, biosafety, and rapid and accurate determination of
resistance to the commonly used anti-tuberculosis drugs. Devel-
opment of such methods is complicated by the extreme slow
growth of M. tuberculosis (doubling time 24 hrs), the presence of
non-tuberculosis strains contaminating patient samples, the
dangers of handling highly infectious agents, and the broad-range
of bacterial densities in sputum samples. None of the currently
available approaches behave perfectly in all facets of an ‘ideal’
diagnostic test.
Mycobacteriophages – viruses of mycobacterial hosts – offer
several potential advantages to tuberculosis diagnostic strategies, in
that they efficiently and specifically infect and replicate in
mycobacteria, and several phage-based approaches have been
developed. The commercially available phage amplification biolog-
ical assay (FASTPlaqueTM, Biotech Labs Ltd) utilizes M. tuberculosis-
dependent reproduction of phage D29 and determination of viral
particle counts on the fast-growing Mycobacterium smegmatis [6,7], and
has been adapted for determining resistance to rifampicin [8]. The
luciferase reporter phage assay uses recombinant mycobacterio-
phages carrying the firefly luciferase gene to detect M. tuberculosis by
luminescence, coupled with empirical determination of drug
resistance by light emission in the presence of antibiotic [9]. Both
methods are rapid, accurate, and simple, but are not well-suited for
the detection of partially-resistant cultures, require the propagation of
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potentially infectious live cultures, and the high level of sensitivity in
laboratory grown cultures has yet to be fully replicated with clinical
specimens [10–12]. A detailed comparison of bacteriophage-based
and other tests for detection of M. tuberculosis in clinical samples has
been described previously [13,14].
Here we report the construction of a new group of reporter
mycobacteriophages that contain the fluorescent reporter genes,
gfp or ZsYellow. These fluoromycobacteriophages have advanta-
geous features in pre-clinical analyses including rapid and sensitive
identification of M. tuberculosis cells, detection by either fluorescent
microscopy or flow cytometry, simple determination of antibiotic
susceptibility profiles, and detection of drug resistant cells within
mixed cultures. Moreover, fluorescence is maintained for at least
two weeks following fixation of samples with paraformaldehyde,
increasing biosafety and facilitating storage or transportation of
samples during diagnosis.
Results
Construction of Fluoromycobacteriophages
Although luciferase reporter mycobacteriophages have been
derived from phages TM4, D29, L5, and Che12 [9,15–17], we
chose to construct and evaluate fluorophage derivatives of TM4
[18,19], since shuttle phasmid derivatives of TM4 are relatively
simple to manipulate [20,21], conditionally-replicating mutants of
TM4 are available [21], and TM4 luciferase reporter phages have
been most extensively evaluated [11,22–25]. TM4 has a broad host-
range among mycobacterial strains and infects both fast-growing and
slow growing strains includingM. tuberculosis. TM4 shuttle phasmids –
phage-cosmid chimeras – have been used to deliver transposons [26],
allelic exchange substrates [27] and reporter genes, and its complete
genome sequence is available [19]. The conditionally-replicating
derivative phAE87 is unable to form plaques or lyse its hosts at 37uC
due to mutations that presumably interfere with DNA replication, but
can be propagated at 30uC [21,26].
To construct fluorophage derivatives of TM4, gfp or ZsYellow
genes were fused to the constitutive M. bovis BCG Hsp60 promoter
in plasmid derivatives of pYUB854 [27] and transferred into the
phAE87 shuttle phasmid to generate phAE87::hsp60-EGFP and
phAE87::hsp60-ZsYellow respectively (Figure 1). DNA was extract-
ed from the E. coli-propagated phasmids and their structures
verified by restriction analysis. High titer stocks (.1010pfu/ml)
were prepared from individual plaques following transfection ofM.
smegmatis, and used in subsequent assays.
Fluorescent detection of M. smegmatis using
fluoromycobacteriophages
To evaluate the ability of phAE87::hsp60-EGFP and
phAE87::hsp60-ZsYellow to confer fluorescence following infection, a
mid-logarithmic culture of M. smegmatis mc2155 was infected at a
multiplicity of infection (moi) of approximately 100, incubated for
4 hours at 37uC, spun and washed, and examined by fluorescence
microscopy (Figure 2). Little or no fluorescence was detected from
uninfected cells, and individual cells could be easily detected following
infection with either phage (Figure 2). To confirm that fluorescence
was specific to infection of M. smegmatis, fluoromycobacteriophages
were used to infect a mixed culture containing approximately
equivalent amounts of M. smegmatis and an Escherichia coli strain
expressing the fluorescent reporter gene DsRed (Figure 3). Green
fluorescence was readily observed only in infected M. smegmatis cells
and in each case was distinct and non-overlapping with the red
fluorescence from E. coli (Figure 3A panels a and b,).
In the experiments shown in Figure 2, approximately 70% of
the cells fluoresce following infection with fluoromycobacterio-
phages. To determine the influence of the multiplicity of infection
(moi) on the proportion of fluorescent cells, M. smegmatis was
infected at a range of moi’s from 0.1 to 100 (Figure 3B). Optimal
efficiencies of fluorescence were observed at an moi of approxi-
mately 10, with fewer fluorescent cells at lower moi’s and
equivalent proportions at moi’s above 10 (Figure 3B). At no moi
were more than approximately 75% of the cells infected, and it is
not clear if the other 25% of cells failed to fluoresce because they
are dead, dormant, uninfectable by TM4, or are infected but do
not express the reporter gene; similar results were obtained for
both phAE87::hsp60-EGFP and phAE87::hsp60-ZsYellow. It should
be noted that these M. smegmatis cultures were grown in the
absence of Tween – a detergent commonly used to generate
dispersed mycobacterial cultures – because Tween is an inhibitor
of TM4 infection. Although cell clumping is therefore one possible
cause for the presence of uninfected cells, microscopy shows that a
high proportion of bacteria are dispersed as single cells (Figure 2).
Since a high proportion of cells fluoresce following infection, we
reasoned that we should be able to detect relatively small numbers
of M. smegmatis bacteria. To evaluate this we made dilutions of an
M. smegmatis culture and infected 200 ml aliquots each with
phAE87::hsp60-EGFP at an moi of 100. In order to recover all of
the bacteria present in the sample, infected cells were collected on
a 0.45 mm filter (GH polypro, PALL Life Sciences) and examined
directly by fluorescence microscopy (Figure 4). When as few as 100
cells were present in the sample, we could readily recover and
identify them by examination of just a few microscopic fields (at
400-fold magnification) (Figure 4E). This experiment shows that
infection is sufficiently efficient even when cells are dilute, and that
because microscopic detection enables identification of individual
infected cells the overall sensitivity of the assay is restricted
primarily by the efficiency with which cells can be recovered for
microscopy. We note that the opacity of these filters eliminates the
ability to determine total bacterial counts using bright field optics.
Figure 1. Fluoromycobacteriophages construction. Schematic
representation of phAE87::hsp60-EGFP construction. Shuttle phasmid
phAE87 is a conditionally replicating derivative of phage TM4 in which
the cosmid moiety is flanked by Pac I restriction sites. A plasmid
derivative of pYUB854 containing the EGFP gene (pMP14) was used to
replace the cosmid in phAE87 followed by lambda packaging and
recovery in E. coli.
doi:10.1371/journal.pone.0004870.g001
Fluoromycobacteriophages
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Detection of fluorescent cells after paraformaldehyde
fixation
A potential advantage of using GFP as a reporter is that it is
known to withstand fixation when expressed in eukaryotic cells
[28]. Paraformaldehyde fixation of fluoromycobacteriophage-
infected mycobacteria has two key potential advantages. First, it
should confer significant biosafety advantages especially when
analyzing notably hazardous strains such as XDR-TB, simplifying
sample handling procedures such as microscopy and flow
cytometry. Secondly, by preserving fluorescence for extended
periods of time, samples could be readily stored or transported for
off-site analysis. We evaluated this using M. smegmatis, adding 2%
paraformaldehyde – which effectively kills mycobacteria [29] –
after phage incubation. Samples were stored at 4uC for varying
periods of time and examined by microscopy. As shown in
Figure 5, fluorescence was maintained following fixation and
showed only modest decay during a two-week incubation.
Incubation for a shorter period (48 hours) at room temperature
showed no reduction of fluorescence (data not shown).
Detection of Mycobacterium tuberculosis using
fluoromycobacteriophages
Using the avirulent strain M. tuberculosis mc26230 [30,31],
bacteria could be readily detected by fluorescence following
fluoromycobacteriophage infection in a similar assay configuration
to that used for M. smegmatis (Figure 6). However, in one
prominent departure, fluorescence was weak after only 4 hours
incubation following infection, and improved greatly after
16 hours (Figure 6); incubation for up to 30 hours provided no
further increase in fluorescence. In a standard assay, M. tuberculosis
cells were incubated overnight with phAE87::hsp60-EGFP, fixed
with 2% paraformaldehyde, washed, resuspended in buffer, and
examined by microscopy. Using a moi of 100, approximately 50%
of cells fluoresced, although this proportion varied significantly
between experiments and ranged from 37–67% with the highest
proportions obtained when cells were grown to late logarithmic
growth and in the absence of detergent (Table S1).
Antibiotic Susceptibility Testing of M. tuberculosis with
Fluoromycobacteriophages
To confirm that gfp expression following fluoromycobacterioph-
age infection is responsive to antibiotics, an M. tuberculosis mc26230
culture was grown (in the absence of Tween), spun and washed,
and phage added with either rifampicin or streptomycin
simultaneously (Figure 7A panels a and c), incubated for 16 hours
and examined by microscopy; in both experiments fluorescence
was eliminated by antibiotic addition. Isogenic rifampicin-resistant
and streptomycin-resistant derivatives of M. tuberculosis mc26230
were constructed by recombineering with ssDNA substrates [32] –
introducing a S456L substitution in rpoB (Rv0667) and a K43R
substitution in rpsL (Rv0682), respectively – and tested in a similar
assay (Figure 7A panels b and d). Antibiotic resistant strains
fluoresced well in the presence of antibiotic (Figure 7A panels b
and d) demonstrating that fluoromycobacteriophages can provide
a report of resistance/susceptible profiles of M. tuberculosis to
rifampicin and streptomycin in approximately 16 hours. Because
isoniazid (INH) is an inhibitor of mycobacterial cell wall synthesis
rather then gene expression, cultures were pre-incubated with
INH for 48 hours prior to addition of fluoromycobacteriophage;
however, fluorescence was unaffected even in INH-sensitive
bacteria (Figure 7A, panel e). Although a variety of pre-incubation
times and drug concentrations have been examined using cells
grown in these conditions, no significant influence of INH on
fluorescence was observed (data not shown).
Other investigations have tested INH susceptibilities using
cultures grown in the presence of Tween detergent to facilitate cell
dispersion [9], so we also tested Tween-grown M. tuberculosis
cultures (Figure 7B). In these experiments, following growth with
Tween, cells were centrifuged, washed twice, and resuspended in
the presence of antibiotic. After incubation for 24 hours, phage
were added, incubated for a further 16 hours, and examined by
microscopy (Figure 7B). Under these conditions, isoniazid as well
as rifampicin and streptomycin strongly reduced fluorescence in
drug sensitive cells (Figure 7B panels a, c, e). Resistant strains all
failed to respond to the addition of antibiotic (Figure 7B panels b,
d, f) showing that under these conditions all fluoromycobacter-
iophages can be used to determine INH as well as rifampicin and
streptomycin susceptibility profiles. It is not clear why growth in
the presence of Tween would strongly enhance the effect of INH
in this assay, although we favor the explanation that it results in
inhibition of phage infection, rather than a metabolic function
necessary for GFP expression and fluorescence.
Determination of drug susceptibilities using
fluoromycobacteriophages and flow cytometry
Flow cytometry offers an alternative approach to the detection
of fluorescence following fluoromycobacteriophage infection.
Figure 2. Detection of M. smegmatis mc2155 cells with
fluoromycobacteriophages. Infection of M. smegmatis with A,
phAE87::hsp60-EGFP; C, phAE87::hsp60-ZsYellow, or B and D, mock
infected controls. Left, fluorescence micrograph images; right, merged
fluorescence and phase contrast images. Scale bar, 10 mm.
doi:10.1371/journal.pone.0004870.g002
Fluoromycobacteriophages
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While the instrumentation required might seem prohibitively
costly for routine use in many areas of the world where the
incidence of tuberculosis is high, if the HIV infection rates are also
high, flow cytometry may have been previously established for
CD4 count determination; the province of KwaZulu-Natal in
South Africa is one example of this. To evaluate this approach, M.
tuberculosis cells infected with phAE87::hsp60-EGFP cells were fixed,
and analyzed by flow cytometry to measure side light scatter as
well as fluorescence (Figure 8A). Although M. tuberculosis has
significant autofluorescence as seen in the mock-infected cells
(Figure 8A panels a and c), fluoromycobacteriophage-infected cells
can be readily distinguished (Figure 8A panels b and c) and a very
high proportion of cells fluoresced following fluoromycobacter-
iophage infection (Figure 8).
Addition of either rifampicin or streptomycin simultaneously
with phage to a drug sensitive strain shifted the signal observed
with phage-infected cells to one superimposable with uninfected
cells (Figure 8A panels d and e), whereas addition to antibiotic to a
resistant strain did not alter the profile of expression from
untreated cells (Figure 8A panels g and h). The drug susceptibility
profiles were therefore clearly discerned and the fluorescent
patterns strongly reflect those observed by microscopy (Figure 7).
When similar assays were performed with as few as a total of 104
bacteria, the efficiency of phage infection was reduced somewhat
although susceptibilities to rifampicin and streptomycin could be
easily determined (Figure S1). When the influence of INH addition
was examined a similar response to that shown in Figure 7 was
seen. When cells were grown in the absence of tween, no INH
inhibition of fluorescence (Figure 8A panel f) was observed.
However, when grown with tween, INH strongly inhibited
fluorescence, although the proportion of infected cells was also
affected (Figure 8B). We also observed that fluorescence is
Figure 3. Specificity and efficiency of fluoromycobacteriophage infections. A. A mixture of E. coli cells expressing DsRed-Express and M.
smegmatis were infected with (a) phAE87::hsp60-EGFP or (b) mock infected. From left to right: fluorescence micrograph images using a ZsGreen1
filter (green); fluorescence micrograph images using a HQ:R NX filter (red), merged fluorescence images; phase contrast images. Red cells: E. coli;
green cells: M. smegmatis mc2155 infected with pHAE87::hsp60-EGFP. Scale bar, 10 mm. B. M. smegmatis mc2155 cells were infected with
phAE87::hsp60-EGFP at different multiplicities of infection (moi). Green cells were counted in 15 individual fields and the percentage of fluorescent
cells compared to the total number of cells in phase contrast images determined.
doi:10.1371/journal.pone.0004870.g003
Figure 4. Sensitivity of Fluoromycobacteriophages. Varying numbers of M. smegmatismc2155 cells were infected with pHAE87::hsp60-EGFP at
a moi of 100. After infection at 37uC for 4 hrs, cells were concentrated by filtration and visualize using by fluorescence microscopy. A, 106; B,105; C,
104; D, 103 and E, 102 cells. Scale bar, 20 mm.
doi:10.1371/journal.pone.0004870.g004
Fluoromycobacteriophages
PLoS ONE | www.plosone.org 4 March 2009 | Volume 4 | Issue 3 | e4870
responsive to addition of kanamycin generating profiles indistin-
guishable to rifampicin- or streptomycin-treated sensitive cells
(Figure S2). While ethambutol, ethionamide and ofloxacin also
inhibited fluorescence, strong antibiotic inhibition was dependent
on growth in tween, and complete inhibition by ofloxacin required
more extensive pre-incubation in the presence of antibiotic (Figure
S2).
Analysis of partially resistant M. tuberculosis cultures
Because sputum samples may not be phenotypically homoge-
nous cultures, we evaluated the ability of fluoromycobacterio-
phages to detect drug resistant strains within mixed cultures.
Rifampicin-resistant and rifampicin-sensitive cells were mixed at
varying ratios, and tested with phAE87::hsp60-EGFP in the
presence of rifampicin (Figure 9). To optimize recovery of bacteria
present in the sample, cells were fixed and recovered on a
0.45 mM filter after phage infection as described above. In samples
containing a total of approximately 106 cells in a 200 ml aliquot,
rifampicin-resistant cells could be readily detected when they
constituted as few at 1% of the total population using a 4006 or
10006 fold magnification (Figure 9E). A similar experiment was
performed using flow cytometry and similar results were observed
with detection of a very small population (1%) of rifampicin
resistant cells when a mixed culture of sensitive and resistant cells
was infected in the presence of rifampicin (Figure 10). We note
that the number of drug-resistant cells rather than the total
number of bacteria determines the sensitivity of detection in such
mixed cultures.
Direct drug susceptibility testing of M. tuberculosis
colonies
The ability to rapidly determine the drug susceptibility profiles
of M. tuberculosis colonies grown on solid medium is potentially
useful in clinical settings as well as in the research laboratory. To
test this, single M. tuberculosis colonies were resuspended in a small
volume (400 ml) of media and the suspension passed several times
through a syringe to disperse clumps. Phage and antibiotics were
added simultaneously, incubated for 16 hours, fixed, collected on
a filter, and analyzed by fluorescence microscopy. Strong
fluorescence was observed with accurate reporting of the drug
susceptibility profiles for rifampicin, streptomycin and kanamycin
(Figure S3).
Discussion
The emergence of MDR and XDR TB strains and the
problems encountered in controlling these infections emphasizes
the need for a rapid, sensitive, and accurate diagnostic test for
tuberculosis drug susceptibility testing. Here we have shown that
fluoromycobacteriophages have features suggesting they have
potential advantages over current diagnostic tools including
luciferase reporter phages and phage amplification assays.
Fluoromycobacteriophages are sensitive to commonly used anti-
tuberculosis drugs including rifampicin, streptomycin and kana-
mycin – with the notable exception of INH when grown in the
absence of Tween – and readily discriminate between drug
resistant and sensitive strains. The assay does not require addition
of any exogenously added substrates and chemical fixation
provides a high level of biosafety, reducing major risks in
analyzing potentially infectious agents by both microscopy and
flow cytometry. The rapid time-to-death reported for XDR-TB
patients in Tugela Ferry [4] – coupled with capable transmission
of these strains [33] – emphasizes the need for a rapid drug
susceptibility test that can be performed locally, rather than in
centralized facilities. While DNA-based assays provide a rapid and
effective approach it is less clear if these can be performed at the
Figure 5. Paraformaldhyde fixation of fluoromycobacterioph-
age-infected mycobacteria. M. smegmatis mc2155 cells were
infected with phAE87::hsp60-EGFP and fluorescence detected in A, live
cells, B, fixed cells and C, fixed cells after 2 weeks at 4uC. Top,
fluorescence micrograph images; bottom, merge of fluorescence and
phase contrast images. Scale bar, 10 mm.
doi:10.1371/journal.pone.0004870.g005
Figure 6. Infection of M. tuberculosis mc26230 cells with
fluoromycobacteriophages. M. tuberculosis was infected with
phages as follows: A, phAE87::hsp60-EGFP; C, phAE87::hsp60-ZsYellow;
B and D, mock infected controls. Cells were fixed with 2%
paraformaldehyde, washed, and resuspended in PBS prior to micros-
copy. Left panels, fluorescence micrograph images; right panels,
merged fluorescence and phase contrast images. Scale bar, 10 mm.
doi:10.1371/journal.pone.0004870.g006
Fluoromycobacteriophages
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point of patient contact with drug susceptibility determination
within a sufficient time frame necessary to treat TB infections with
an appropriate drug regimen, and that avoids XDR-TB
transmission.
The pre-clinical properties of the fluoromycobacteriophages
satisfy the criteria for a simple, rapid, sensitive, safe, and accurate
test for tuberculosis drug susceptibilities. Evaluation of this
technology in a clinical setting will require optimization of sputum
processing for efficient phage infection, and we note that while
sputum processing methods have been described for use of
luciferase reporter phages and commercially available FastPla-
queTM phage amplification assays [11,34], efficient infection of
mycobacteria derived from sputum has thus far limited replication
of the pre-clinical performance of these methods in clinical settings
[13,14]. Efficient recovery of phage-infectable M. tuberculosis cells
from sputum is thus anticipated to be a key factor in clinical
implementation of the fluoromycobacteriophage assay described
here, as it is for other phage-based assays. An additional limitation
of using phage TM4 as a fluoromycobacteriophage platform is
that it does not discriminate between M. tuberculosis and non-
tuberculous mycobacterial strains. This could potentially be
addressed by either switching to an alternative phage platform
with a more restricted host range, by engineering of TM4, or
through addition of hydroxypropiophenone (NAP) that selectively
inactivate M. tuberculosis complex bacteria [11]. However, we also
note that TM4 has a potential advantage in that it efficiently
infects mycobacterial cells that have entered stationary phase as a
function of a peptidoglycan hydrolyzing motif in the phage
tapemeasure protein [35].
Fluorescence microscopy coupled with compatible filters –
which are also available in a multi-well format – enables the
detection of small numbers of cells using a low power objective lens
and larger microscope fields [36,37]. Although fluorescent
microscopy may be prohibitively costly in many areas of high
tuberculosis incidence due to its cost and short life spans of light
sources, two facets of the fluoromycobacteriophage assay suggest
potential solutions. First, because samples can be fixed prior to
slide preparation without loss of fluorescence, microscopy could be
Figure 7. Antibiotic susceptibility testing of M. tuberculosis using fluoromycobacteriophages. M. tuberculosis mc26230 wt and antibiotic
resistant strains were infected with phAE87::hsp60-EGFP with or without antibiotic addition as indicated. A. Cultures were grown in the absence of
Tween, washed, and tested. In panels a–d antibiotics and phage were added simultaneously, incubated for 16 hours, and examined by microscopy.
In panels e–f INH was added first for 48 hours followed by phage addition, incubation for a further 16 hours, and examined by microscopy. Scale bar,
10 mm. B. Cultures were grown in the presence of Tween, centrifuged and washed twice, and then incubated with antibiotic (as indicated) for
24 hours. Phage were then added, cultures incubated for 16 hour, and examined by microscopy. Scale bar, 20 mm.
doi:10.1371/journal.pone.0004870.g007
Fluoromycobacteriophages
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performed at a central facility serving nearby communities, even
though this would extend the total time to obtain assay results.
Secondly, less expensive and simpler fluorescent microscopes using
light emitting diodes (LED) have been developed for the use of
auramine-stained M. tuberculosis samples [38], and these could
readily be adapted for detection of fluoromycobacteriophage
infected cells.
Flow cytometry has been described previously for M. tuberculosis
diagnosis [39] and has the advantage that flow cytometers are
already in use in many areas of high HIV incidence. For example,
M. tuberculosis can be detected by fluorescence from hydrolysis of
fluorescein diacetate, and susceptibilities to isoniazid, ethionamide
and rifampicin determined in 24 hours, although aerolisolization
of unfixed viable cells is a significant concern [40]. Safe cytometric
methods using fluorescent dyes to measure bacterial growth in the
presence or absence of antibiotics have also been described
although they require somewhat longer times-to-detection
(72 hours) [41,42]. Mycobacteriophages have some advantage
over these methods by virtue of their specificities for mycobacterial
hosts such that fluorescence is dependent on phage infection.
Furthermore, flow cytometry provides simple discrimination of
drug resistant and drug sensitive M. tuberculosis cells, with high
sensitivity of detection. Using the pre-clinical assay configuration
in which rifampicin, streptomycin or kanamycin are added
simultaneously with phage, a large number of samples can be
analyzed in a short period of time (,1 minute for each sample by
flow cytometry), and drug susceptibilities determined within
16 hours. Importantly, fixation of the sample prior to analysis
overcomes substantial biosafety concerns experienced with other
methods for drug susceptibility determination using flow cytom-
etry [40]. Finally, flow cytometric analysis of fluoromycobacter-
iophage infected cells is not significantly impeded by M. tuberculosis
clumping, even when grown in the absence of Tween detergent.
Responsiveness of the fluoromycobacteriophage assay to
rifampicin and streptomycin was not unexpected, since these
antibiotics are known to inhibit mycobacterial gene expression;
fluorescence is also strong inhibited by kanamycin (Figure S2), as
well as by ciprofloxacin and sparfloxacin (Liliana Rondon Salazar
and Howard Takiff, personal communication). The responsiveness
to INH is more complex, and when cells are grown in the absence
of Tween, INH addition does not significantly inhibit fluorescence
in any configuration that we have tested. In contrast, growth in
Tween – followed by INH preincubation for 24 hrs and phage
addition leads to strong abrogation of GFP fluorescence in
sensitive, but not resistant cells. This suggests that fluoromyco-
bacteriophages can be used to evaluate INH susceptibilities
although the requirement for pre-incubation with Tween may
extend this assay to longer than 48 hours. This assay was further
complicated by the presence of a sub-population of cells (0.1–1%)
that fluoresced in the presence of INH and could be detected
microscopically; these likely correspond to persisters that display
INH tolerance due to their metabolic state (C. Vilcheze and WRJ;
unpublished observations). Finally, we note that fluorescence was
also not subject to INH inhibition when individual colonies from
solid media were tested, although these were also analyzed in the
absence of Tween growth and a significant number of cells may
not be in a growth-dependent INH-sensitive state. The use of
INH-responsive promoters [43] may be useful for addressing this.
In summary, fluoromycobacteriophages offer a potentially
powerful new approach to the detection and antibiotic suscepti-
bility testing of tuberculosis infections, combining established
methods for phage-based testing with microscopic or flow
cytometry approaches. The ability to directly visualize the drug
susceptibility profile allows for the analysis of small numbers of
cells, is both specific and fast, and can detect resistant strains
within mixed populations; rapid detection of rifampicin resistance
Figure 9. Infection of a mixed culture of antibiotic resistant and
sensitive strains. M. tuberculosis mc26230 wt was mixed with the
isogenic RifR strain at different proportions. A total of 106 mixed cells
were infected with phAE87::hsp60-EGFP in the presence of Rifampicin;
cells were fixed, collected by filtration and analyzed by fluorescent
microscopy. (A) 100% wt: 0% RifR (B) 50% wt: 50% RifR; (C) 75% wt :25%
RifR ; (D) 90% wt :10% RifR; (E) 99% wt :1% RifR. Left panels, fluorescence
micrograph images; scale bar 20 mm; right panels, fluorescence
micrograph images, scale bar 10 mm.
doi:10.1371/journal.pone.0004870.g009
Figure 8. Fluoromycobacteriophage M. tuberculosis susceptibility testing using flow cytometry. A. M. tuberculosis mc26230 strains grown
in the absence of Tween detergent were infected with phAE87::hsp60-EGFP with or without antibiotic treatment, fixed with paraformaldehyde, and
analyzed by flow cytometry. In panels a, mock-infected control cells and b, phage infected cells, the intensity of fluorescence is plotted against light
side scatter. The signal observed in mock-infected cells corresponds to autofluorescence of M. tuberculosis and the shift towards greater fluorescence
in phage-infected cells shows that a high proportion of cells are infected and expressed GFP. In panels c–i the level of fluorescence is plotted against
the number of events counted. In each experiment mock-infected cells are shown in red, phage infected cells in green, and antibiotic-treated phage
infected cells in blue. When treated with rifampicin (Rif) or streptomycin (Str) antibiotics were added simultaneously with phage (w), incubated for
16 hours, fixed and analyzed; for INH treatment cells were pre-incubated with antibiotic for 48 hours, incubated with phage for 16 hours, fixed, and
analyzed. B. M. tuberculosis mc26230 strains were grown in the presence of Tween, washed, preincubated with isoniazid for 24 hours, infected with
phAE87::hsp60-EGFP, fixed, and analyzed by flow cytometry. Panels a–e correspond to panels a–c, f, and i of Figure 8A respectively.
doi:10.1371/journal.pone.0004870.g008
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as a marker for suspected MDR-TB and XDR-TB [44] would be
especially useful. We reported the detection of just 1% of resistant
cells to rifampicin in a mixed population, comparable to the
sensitivity of the agar proportion method on Lowenstein-Jensen
medium and Middlebrook 7H11 agar that is an established
standard for susceptibility testing of M. tuberculosis [45].
Materials and Methods
Bacterial strains
M. smegmatis mc2155 has been described previously [46]. M.
tuberculosis mc26230 is a derivative of H37Rv and contains a
deletion of the RD1 region and panCD, resulting in a pan2
phenotype [31]. All culture media were supplemented with
panthothenate (100 mg ml21) and the following antibiotics when
required: kanamycin (20 mg ml21 or 4 mg ml21 for AST),
streptomycin (6 mg ml21), rifampicin (2 mg ml21), isoniazid
(0.4 mg ml21), ethionamide (10 mg ml21), ethambutol (5 mg ml21)
and ofloxacin (10 mg ml21). For AST, drug concentrations were
optimized for discrimination between resistant and susceptible
strains using fluoromycobacteriophages.
Construction of antibiotic resistant mutants
Isogenic rifampicin and streptomycin resistant mutants of M.
tuberculosis mc26230 were constructed by ssDNA recombineering
[32]. Plasmids pJV114F or pLAM12 were introduced into M.
tuberculosis mc26230 by electroporation, and strains were grown and
induced for recombineering functions as described previously [32].
Plasmid pJV114F is a derivative of pJV62 [32] containing a
counterselectable sacB gene. The following ssDNA oligonucleotides
were used for electroporation: JCV327 59 CCCGCT-
GTCGGGGTTGACCCACAAGCGCCGACTGTtGGCGCT-
GGGGCCCGGCGGTCTGTCACGTGAGCGTG 39 and
JCV328 59 CACGCTCACGTGACAGACCGCCGGGCCC-
CAGCGCCaACAGTCGGCGCTTGTGGGTCAACCCCGAC-
AGCGGG 39 to target rpoB (Rv0667) and generate a S456L
mutation; and JCV329 59 TGGTGTATGCACCCGCGTGTA-
CACCACCACTCCGAgGAAGCCGAACTCGGCGCTTCGG-
AAGGTTGCCCGCG 39 and JCV330 59 CGCGGGCAA-
CCTTCCGAAGCGCCGAGTTCGGCTTCcTCGGAGTGG-
TGGTGTACACGCGGGTGCATACACCA 39 to target rpsL
(Rv0682) and generate a K43R mutation. Electroporations were
performed with 100 ng of each ssDNA oligonucleotide and
recovered for 3 days in 7H9 medium supplemented with
Middlebrook OADC Enrichment (Becton Dickinson and Company
Sparks, MD), Tween-80, panthothenate (100 mg ml21) and plated
on 7H10 agar containing OADC, panthothenate (100 mg ml21)
and the appropriate antibiotic. To cure the strains of plasmid
pJV114F, isolated colonies were grown in liquid media in the
absence of kanamycin until saturation and sub-cultured at high
dilution. After growth, cells were plated on 7H10 OADC,
panthothenate (100 mg ml21) with the appropriate antibiotic plates
in the presence of 10% sucrose; loss of pJV114F was corroborated
by patching single colonies to sucrose plates in the absence and
presence of kanamycin. In each mutant the rpoB and rpsL region was
sequenced to confirm the presence of the desired point mutation. A
similar approach was used to generate an isoniazid mutant,
although the high level of spontaneous resistant mutants was
problematic. We therefore characterized a spontaneous M.
tuberculosis mc26230 INHR mutant and after sequencing possible
known gene targets we identified a point mutation in katG (Rv1908c)
(H104Q).
Construction of fluoromycobacteriophages
Fluoromycobacteriophage phAE87::hsp60-EGFP was construct-
ed as follows: an Xba I DNA fragment from pJL37GFP [47]
containing the EGFP gene under control of the BCG Hsp60
promoter was cloned in pYUB854 [27] to generate plasmid
pMP14, which was used to replace the pYUB328 vector moiety in
shuttle phasmid phAE87. In brief, phAE87 and pMP14 were
digested with Pac I, ligated and packaged in lambda heads in vitro
using the Gigapack III XL-7 (Stratagene), and used to transduce
E. coli HB101. HygromycinR clones were selected and phasmid
DNAs prepared and characterized by restriction. One phasmid
was used to transfect M. smegmatis mc2155 by electroporation[27],
individual plaques were tested to confirm the presence of EGFP
and a large high titer (1012 pfu/ml) phage stock from a purified
plaque was prepared.
A similar strategy was used to construct pHAE87::hsp60-
ZsYellow, by PCR amplification of ZsYellow from plasmid
pZsYellow (Clontech Laboratories, Inc.) using primers ZsYellowF
59 GGAATTCCATATGGCTCATTCAAAGCACGGT 39 and
ZsYellowR 59 CAGTTGGAATTCTAGAGTCGC 39. The
amplicon was digested with Nde I and EcoR I and inserted in
pJL37 under the control of BCG Hsp60 promoter. After restriction
with Xba I, a fragment containing Hsp60-ZsYellow was cloned in
pYUB854 generating plasmid pMP15 and inserted into phAE87
as described above. All phage dilutions were made in phage buffer
supplemented with 3 mM CaCl2.
Infection of M. smegmatis mc2155 with
fluoromycobacteriophages
M. smegmatis mc2155 cells were grown to an OD600 nm of 1 in
7H9+ADC in the absence of Tween. Approximately 200 ml of
cells were mixed with 100 ml of a phage dilution to obtain an moi
of 100 (or as required), incubated without shaking for 15 min at
37uC and then for 4 h at 37uC with moderate shaking. Five ml
were spotted onto a glass microscope slide, covered with a glass
coverslip, sealed with melted mix of 1:1:1 vaseline: lanoline:
paraffin, and examined by fluorescence microscopy. For cell
fixation, after incubation for 4 h at 37uC 1 volume of 4%
paraformaldehyde in PBS was added and the mix incubated for
30 min at room temperature. Cells were washed with 10%
glycerol twice and resuspended in PBS (,1/10 of original volume)
and examined by microscopy as above.
Moi and percentage of cells infected, specificity and
sensitivity
M. smegmatis mc2155 cells were infected as described above with
the appropriate amount of phage to obtain a multiplicity of
infection (moi) of 100, 10 , 1 or 0.1. After infection, 5 ml of the mix
were spotted on a slide before examination under the microscope.
Fifteen individual fields for each moi used were recorded and the
percentage of fluorescent cells compared to total cells in phase
Figure 10. Detection of M. tuberculosis mc26230 RifR cells in a mixed population using flow cytometry. M. tuberculosis mc26230 wt was
mixed with the isogenic rifR strain at different proportions. A total of 107 mixed cells were infected with phAE87::hsp60-EGFP in the presence of
Rifampicin; cells were fixed and analyze by flow cytometry. (A) 100% wt: 0% RifR (B) 50% wt: 50% RifR; (C) 75% wt : 25% RifR ; (D) 90% wt :10% RifR; (E)
99% wt :1% RifR . Left panels, the intensity of fluorescence is plotted against light side scatter; right panels, the level of fluorescence is plotted against
the number of events counted.
doi:10.1371/journal.pone.0004870.g010
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contrast images was calculated. The % mean6SD was calculated
for each moi.
E. coli DH5a competent cells were transformed with pDsRed-
Express (Clontech Laboratories, Inc.), grown to exponential phase
and mixed with a culture of M. smegmatis mc2155. The mixed
culture was infected with pHAE87::hsp60-EGFP for 4 hours at
37uC, cells were fixed as described above and 5 ml examined
under a fluorescence microscope using a red or green filter.
To evaluate the sensitivity of detection, 200 ml of 10-fold
dilutions of M. smegmatis mc2155 cells (initial cell number 16108/
ml) were infected with the appropriate amount of pHAE87::hsp60-
EGFP to maintain a moi of 100 for 4 hours at 37uC. After
infection, cells were fixed with paraformaldehyde as described
above, filtered through a GH polypro 0.45 mm filter, 13 mm
(PALL Life Sciences) and washed three times with one volume of
PBS. The damp filter was placed on a microscope slide and
immersion oil and a cover slip were placed on top [48]and sealed
as described above. Ten fields were examined to determine the
minimal number of cells that could be detected.
Detection and antibiotic susceptibility testing (AST) of M.
tuberculosis mc26230 with fluoromycobacteriophages
M. tuberculosis mc26230 cells were grown until an OD600 nm of 1
in 7H9+OADC+0.05% Tween 80+panthothenate in the presence
of carbenicillin (CB) (50 mg ml21) and cycloheximide (CHX)
(10 mg ml21). When antibiotic resistant strains were used, the
appropriate antibiotic was added to the culture at the concentra-
tions indicated above. Cells were washed twice in fresh media
(7H9+OADC without Tween and CB and CHX) and resuspended
in the same media at an OD600 nm of 0.5. When performing AST,
antibiotics were added at this step. Cells were incubated standing
for 24 hours (when RIF and STR was used) and 24–48 hours for
INH. This step is necessary to eliminate traces of Tween that
inhibit phage infection and was used to pre-incubate the cells with
antibiotic. After that period, cells were spun down and
resuspended in fresh media in the presence of antibiotic. For
infection of cells grown in the absence of Tween the protocol
described for flow cytometry detection was followed (described in
detail below). Approximately 200 ml of cells were mixed with
100 ml of a phage dilution to obtain a moi of 100. The mix was
incubated standing for 15 min at 37uC and for 16–18 h
(overnight) at 37uC with moderate shaking. For all experiments
using M. tuberculosis mc26230 cells were fixed and washed as
described for M. smegmatis after incubation with paraformaldehyde
for 1.5 hours. Counting of colony forming units (CFU) was
routinely done after this incubation to ensure that no viable cells
were present. For assays using mixed cultures (wt and antibiotic
resistant strains), cells were mixed at the indicated proportion
before preincubation with the antibiotics.
To infect cells from a colony, cultures from M. tuberculosis
mc26230 wt and antibiotic resistant strains were streaked out on
7H11 plates and incubated for 2–3 weeks at 37uC. A single colony
was resuspended in 400 ml of 7H9+OADC+panthothenate,
vortexed for 2 minutes and passed several times through a syringe
with a 23 gauge needle. Cell suspensions were left standing for
5 minutes and 200 ml of the supernatant were mixed with 100 ml
of a phage dilution to obtain a moi of 100 (assuming about 106
cells/colony). For AST, phage and antibiotics were added at the
same time. The mix was incubated standing for 15 min at 37uC
and for 16–18 h (overnight) at 37uC with moderate shaking. After
that, cells were fixed with paraformaldehyde 2% for at least
1.5 hrs. Cells were concentrated by filtration as described above
and examined by fluorescence microscopy.
Microscopy and settings
A fluorescence microscope (Axiostar Plus; Carl Zeiss) with a 406
objective and a 1006 objective with oil immersion and phase
contrast was used. Fluorescent images were acquired using an
AxioCam MRc5 camera (Carl Zeiss) and Carl Zeiss AxioVision
Rel. 4.6 software. In all experiments the same exposure time was
used for infected cells and mock infected cells. For detection of
fluorescent proteins the following filters were used: for EGFP,
CLON ZsGreen1 (42002- HQ 470/30X, HQ 520/40m, Q495LP);
for ZsYellow, CLON ZsY1 (42003- HQ500/35X, HQ550/40m,
Q525LP); for DsRed-Express, HQ:R NX (41002c- HQ545/30X,
HQ620/60m, Q570LP) from Chroma Technology Corporation.
Image processing was performed using Adobe Photoshop CS2
(Adobe Systems Incorporated), but maintaining identical brightness
and contrast settings for images of infected cells and controls.
Flow Cytometry
M. tuberculosis mc26230 wt and antibiotic resistant strains were
grown until saturation in the presence of Tween as described
above, sub-cultured in 10 ml of 7H9+OADC panthothena-
te+CB+CHX without Tween at an initial OD600 nm of 0.1 and
grown standing until an OD600 nm of about 1; antibiotics were
added at the indicated concentrations as appropriate. Cells were
spun down and resuspended in fresh media (without CB and
CHX) to an OD600 nm of 0.5 and passed several times through a
syringe with a 23 gauge needle. Phage infections were performed
as described above for the colony protocol, but after fixation cell
suspensions were kept at 4uC until use, no washing step was
necessary before injection of the samples in the flow cytometer.
Analysis was performed with a Beckman-Coulter CYAN ADP
(Beckman-Coulter, Fullerton, CA) flow cytometer with Summit
4.3 software (Dako Colorado Inc.).
To assay the minimum number of cells that could be detected
by flow cytometry, serial dilutions were made and 100 ml of cells
were infected with a small amount (0.25 ml) of a phage
concentrated stock (1013 PFU/ml). Infection was done in the
presence of 1 mM CaCl2 and cells incubated as described above;
100 ml of paraformaldehyde 4% (2% final concentration) was
added to fix cells for at least 1.5 hrs before analysis.
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